A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer

PURPOSE: PANVAC is a recombinant poxviral vaccine that contains transgenes for MUC-1, CEA and 3 T-cell costimulatory molecules. This study was conducted to obtain preliminary evidence of clinical response in metastatic breast and ovarian cancer patients. EXPERIMENTAL DESIGN: Twenty-six patients were...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Mohebtash, Mahsa, Tsang, Kwong-Yok, Madan, Ravi A., Huen, Ngar-Yee, Poole, Diane J., Jochems, Caroline, Jones, Jacquin, Ferrara, Theresa, Heery, Christopher R., Arlen, Philip M., Steinberg, Seth M., Pazdur, Mary, Rauckhorst, Myrna, Jones, Elizabeth C., Dahut, William L., Schlom, Jeffrey, Gulley, James L.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2011
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3227395/
https://ncbi.nlm.nih.gov/pubmed/22068656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-0649
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge